PET/MR User's Meeting: Technical challenges Feb 05, 2020 10:30 AM - 03:00 PM — Henry Wellcome Auditorium, 183 Euston Road, London
Launch event for Aberdeen Hub of One HealthTech Feb 13, 2020 06:00 PM - 09:00 PM — ONE Tech Hub, Schoolhill, Aberdeen
Scottish Ophthalmic Imaging Society meeting Feb 14, 2020 09:30 AM - 05:00 PM — Royal Society of Edinburgh, 22-26 George Street, Edinburgh
Scottish+ Radiotherapy Physics Meeting 2020 Feb 21, 2020 09:30 AM - 05:00 PM — Scottish Health Service Centre , Western General Hospital, Edinburgh
2nd Scottish Ultrasound Annual Scientific Meeting Feb 28, 2020 10:00 AM - 05:00 PM — Collins Building, University of Strathclyde


SINAPSE experts from around Scotland have developed ten online modules designed to explain medical imaging. They are freely available and are intended for non-specialists.

Edinburgh Imaging Academy at the University of Edinburgh offers the following online programmes through a virtual learning environment:

Neuroimaging for Research MSc/Dip/Cert

Imaging MSc/Dip/Cert

PET-MR Principles & Applications Cert

Applied Medical Image Analysis Cert

Online Short Courses

18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's disease

Author(s): E. Calamai, S. Dall'Angelo, D. Koss, J. Domarkas, T. J. McCarthy, M. Mingarelli, G. Riedel, L. F. Schweiger, A. Welch, B. Platt, M. Zanda

Three fluoro-barbiturates were synthesised, showing in vivo sedative efficacy. One of them, [(18)F], was synthesised in radiofluorinated form. PET/CT Imaging with [(18)F] identified beta-amyloid over-expressing transgenic mice (betaA mice) compared to wild type and tau lines. The fluorescent barbiturate 9 was able to label betaA plaques in brain sections of betaA mice, and co-localise with a fluorescent Zn(II) indicator.

Full version: Available here

Click the link to go to an external website with the full version of the paper

ISBN: 1364-548X (Electronic)1359-7345 (Linking)
Publication Year: 2013
Periodical: Chem Commun (Camb)
Periodical Number: 8
Volume: 49
Pages: 792-4
Author Address: Kosterlitz Centre for Therapeutics, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Scotland, UK.